BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9788544)

  • 1. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
    Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
    Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
    Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
    Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S; Kihara Y; Otsuki M
    Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of proteases in cerulein-induced pancreatitis.
    Yamaguchi H; Kimura T; Mimura K; Nawata H
    Pancreas; 1989; 4(5):565-71. PubMed ID: 2478999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do plasma and urine trypsinogen activation peptides (TAP) really increase in trypsin-taurocholate-induced pancreatitis?
    Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
    Pancreas; 2000 May; 20(4):389-93. PubMed ID: 10824694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
    Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
    Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
    Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
    Yamano M; Umeda M; Miyata K; Yamada T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):253-63. PubMed ID: 9750012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
    Nakano S; Tachibana I; Otsuki M
    Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
    Paterniti I; Mazzon E; Riccardi L; Galuppo M; Impellizzeri D; Esposito E; Bramanti P; Cappellani A; Cuzzocrea S
    Surgery; 2012 Jul; 152(1):90-106. PubMed ID: 22521259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new cholecystokinin receptor antagonist (KSG 504) on the early stage of the healing process in acute pancreatitis induced in rats by the closed duodenal loop technique.
    Ha S; Satake K; Hiura A; Sowa M; Nishiwaki H
    Pancreas; 1994 Jul; 9(4):501-7. PubMed ID: 7524065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats.
    Takabayashi F; Harada N
    Pancreas; 1997 Apr; 14(3):276-9. PubMed ID: 9094158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exocrine pancreatic function in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Pancreas; 1997 Jul; 15(1):83-90. PubMed ID: 9211497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of octreotide pretreatment in experimental acute pancreatitis.
    Salem MZ; Cunha JE; Coelho AM; Sampietri SN; Machado MC; Penteado S; Abdo EE
    Pancreatology; 2003; 3(2):164-8. PubMed ID: 12748426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MCI-727 on pancreatic exocrine secretion and acute pancreatitis in two experimental rat models.
    Tachibana I; Watanabe N; Shirohara H; Akiyama T; Nakano S; Otsuki M
    Pancreas; 1996 Mar; 12(2):165-72. PubMed ID: 8720664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
    Pescador R; Manso MA; Rebollo AJ; de Dios I
    Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
    Jurkowska G; Grondin G; Massé S; Morisset J
    Gastroenterology; 1992 Feb; 102(2):550-62. PubMed ID: 1370663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat.
    Tito JM; Rudnicki M; Jones DH; Alpern HD; Gold MS
    Am J Surg; 1993 Jun; 165(6):690-6. PubMed ID: 7685154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H
    Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
    Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
    Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.